{
  "users": [
    { "id": 1, "name": "Alice", "email": "alice@example.com" },
    { "id": 2, "name": "Bob", "email": "bob@example.com" }
  ],
  "products": [
    { "id": 1, "name": "Laptop", "price": 1299.99 },
    { "id": 2, "name": "Phone", "price": 699.99 }
  ],
  "orders": [
    { "id": 1, "userId": 1, "productId": 2, "quantity": 1 },
    { "id": 2, "userId": 2, "productId": 1, "quantity": 2 }
  ],
  "logout": {},
  "authData": {
    "token": "mock-auth-token-12345",
    "permissions": ["user"],
    "role": "user"
  },
  "userProfile": {
    "id": 1,
    "name": "Test User",
    "email": "user@example.com",
    "role": "user",
    "permissions": ["user"]
  },
  "userData": {
    "data": [1, 2, 3, 4, 5]
  },
  "credentials": [
    {
      "id": 1,
      "email": "admin@example.com",
      "password": "admin123",
      "role": "admin",
      "permissions": ["admin", "user"]
    },
    {
      "id": 2,
      "email": "user@example.com",
      "password": "user123",
      "role": "user",
      "permissions": ["user"]
    }
  ],
  "sellers": [],
  "buyers": [
    {
      "id": 1,
      "profile_theme": "green",
      "user_name": "user001",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 2,
      "profile_theme": "blue",
      "user_name": "user002",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 3,
      "profile_theme": "red",
      "user_name": "user003",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 4,
      "profile_theme": "green",
      "user_name": "user001",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 5,
      "profile_theme": "blue",
      "user_name": "user002",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 6,
      "profile_theme": "red",
      "user_name": "user003",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 7,
      "profile_theme": "green",
      "user_name": "user001",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 8,
      "profile_theme": "blue",
      "user_name": "user002",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 9,
      "profile_theme": "red",
      "user_name": "user003",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 10,
      "profile_theme": "green",
      "user_name": "user001",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 11,
      "profile_theme": "blue",
      "user_name": "user002",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    },
    {
      "id": 12,
      "profile_theme": "red",
      "user_name": "user003",
      "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
      "company_name": "EP Plus Group",
      "company_logo": "/example_logo.png",
      "company_logo_small": "/example_logo_small.png",
      "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
      "company_location": "Taiwan",
      "company_established_year": "2001",
      "company_overview": "/company-overview.jpg",
      "business_annual_revenue": "5000000.00",
      "business_capital_amount": "1000000.00",
      "number_of_employees": 120,
      "company_website": "https://alphamaterials.com",
      "business_attributes": ["Distributor / Agent"],
      "business_nature": ["Pharmaceutical Distribution"],
      "industry_classification": "先進材料",
      "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
      "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
      "required_certification": "ISO 9001",
      "market_channel_overview": "全球OEM廠商",
      "company_strengths": "研發創新速度快",
      "estimated_procurement_amount": "200000.00",
      "brands_in_distribution": "AlphaFiber",
      "time_zone": "UTC+08:00 (Asia/Taipei)",
      "languages": ["English", "Chinese"]
    }
  ],
  "buyers_contact": [
    {
      "id": 1,
      "buyer_name": "Eric Khor",
      "buyer_job_title": "Vice President",
      "brief_introduction": "超過10年材料領域經驗",
      "buyer_contact_location": "Malaysia, Singapore, Indonesia, Philippines",
      "buyer_photo": "/buyer_photo.png"
    },
    {
      "id": 2,
      "buyer_name": "Eric Khor",
      "buyer_job_title": "Vice President",
      "brief_introduction": "超過10年材料領域經驗",
      "buyer_contact_location": "Malaysia, Singapore, Indonesia, Philippines",
      "buyer_photo": "/buyer_photo.png"
    },
    {
      "id": 3,
      "buyer_name": "Eric Khor",
      "buyer_job_title": "Vice President",
      "brief_introduction": "超過10年材料領域經驗",
      "buyer_contact_location": "Malaysia, Singapore, Indonesia, Philippines",
      "buyer_photo": "/buyer_photo.png"
    }
  ],
  "filter_options": {
    "purchasing_requirement": {
      "703": "Smart Hospital & IT Solutions",
      "705": "Diagnostics & Laboratory",
      "706": "Digital Health",
      "707": "Biopharmaceuticals",
      "721": "Medical Devices",
      "722": "Health & Wellness",
      "725": "Long Term Care & Rehab"
    },
    "partnership_looking_for": {
      "710": "CDMO / CMO",
      "711": "OEM / ODM",
      "712": "Co-Development",
      "713": "Technology Licensing"
    },
    "region_covered": {
      "732": "Singapore",
      "733": "Indonesia"
    }
  },
  "recommended": [
    {
      "id": 0,
      "position": "top",
      "theme": "a",
      "image": "/product1.png",
      "name": "Microbiology Consumables"
    },
    {
      "id": 1,
      "position": "top",
      "theme": "b",
      "image": "/product2.png",
      "name": "Diagnostic Imaging Equipment"
    },
    {
      "id": 2,
      "position": "bottom",
      "theme": "a",
      "image": "/product3.png",
      "name": "Da Vinci Surgical Instruments"
    },
    {
      "id": 3,
      "position": "center",
      "theme": "c",
      "name": "2025\nIBMI Caner Medicines\nOnline Live Conference",
      "date": "Aug 19, 19:00-21:00"
    }
  ],
  "conference": {
    "title": "2024 MEDTEX Summit Asia",
    "subtitle": "Leading innovation, investing in the future",
    "date": "2024.12.03(Tue)",
    "location": "3F, Ballroom, Le Méridien Taipei",
    "organizers": ["Everbright Biofund", "RBMP"],
    "supporters": ["National Science and Technology Council (NSTC)", "National Development Council (NDC)"],
    "themes": ["Advanced AI applications", "Regenerative medicine", "Immunotherapies", "Breakthrough drug development", "Innovative medical devices"],
    "logo": "https://expo.taiwan-healthcare.org//data/tmp/20230928/20230928epf7fo.svg",
    "expo_logo": "https://expo.taiwan-healthcare.org//data/tmp/20241104/202411047ytqkg.png",
    "background_image": "https://expo.taiwan-healthcare.org//data/tmp/20230928/202309282l9cde.gif"
  },
  "speakers": [
    {
      "id": 1,
      "name": "Ettikan Karuppiah",
      "title": "Director & Technologist, NVIDIA",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241125/20241125pgynrb.jpg"
    },
    {
      "id": 2,
      "name": "Keren Priyadarshini",
      "title": "Healthcare Lead, Microsoft Asia",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241106/20241106rc6gfu.jpg"
    },
    {
      "id": 3,
      "name": "Charles Lin",
      "title": "Principal, illumina Ventures",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028xc4re6.jpg"
    },
    {
      "id": 4,
      "name": "Robert Mittendorff",
      "title": "General Partner & Head of Healthcare, B Capital",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241122/202411228uf8an.jpeg"
    },
    {
      "id": 5,
      "name": "Ian Chiang",
      "title": "Partner, Flare Capital Partners",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241106/20241106lbsh6z.jpg"
    },
    {
      "id": 6,
      "name": "Nate Chang",
      "title": "Operating Partner, Playground Global",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241118/202411180cv8jj.webp"
    },
    {
      "id": 7,
      "name": "Cheryl Cheng",
      "title": "Founder, Vive Collective",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241108/202411082dgc5h.jpg"
    },
    {
      "id": 8,
      "name": "Zubin Daruwalla",
      "title": "Asia Pacific Health Industries Leader, PwC Singapore",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241107/20241107k8bmq6.jpg"
    }
  ],
  "startups": [
    {
      "id": 1,
      "name": "Tempo Therapeutics",
      "description": "微孔凝膠組織再生全新材料",
      "presenter": "Westbrook Weaver",
      "presenter_title": "Founder/CEO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410285ts46s.jpg",
      "category": "Regenerative Medicine"
    },
    {
      "id": 2,
      "name": "EyeYon",
      "description": "人工眼角膜移植新科技！",
      "presenter": "Nahum Ferera",
      "presenter_title": "CEO/ Co-Founder",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028xqekka.jpeg",
      "category": "Regenerative Medicine"
    },
    {
      "id": 3,
      "name": "EpiBone",
      "description": "創新脂肪幹細胞製程生成骨移植物",
      "presenter": "Nina Tandon",
      "presenter_title": "CEO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028y81103.jpeg",
      "category": "Regenerative Medicine"
    },
    {
      "id": 4,
      "name": "Arbor Biotechnologies",
      "description": "張鋒團隊 !全球最新高效CRISPR平台",
      "presenter": "David Cheng",
      "presenter_title": "CTO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410280h2pfw.jpg",
      "category": "New Drug Development"
    },
    {
      "id": 5,
      "name": "ImmuneBridge",
      "description": "免疫幹細胞擴增技術x精準基因工程",
      "presenter": "Nina Horowitz",
      "presenter_title": "CSO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028r782rx.png",
      "category": "Immunotherapy・Gene Therapy"
    },
    {
      "id": 6,
      "name": "Cirsium Biosciences",
      "description": "獨創植物細胞生產病毒載體技術",
      "presenter": "Jake Connors",
      "presenter_title": "CTO/ Co-Founder",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028e18olj.jpg",
      "category": "Immunotherapy・Gene Therapy"
    },
    {
      "id": 7,
      "name": "Rejuvenate Bio",
      "description": "哈佛團隊研發老化疾病基因療法",
      "presenter": "Daniel Oliver",
      "presenter_title": "CEO/ Co-Founder",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028n6eq6u.jpg",
      "category": "Immunotherapy・Gene Therapy"
    },
    {
      "id": 8,
      "name": "Verlmmune",
      "description": "抗腫瘤免疫重定向創新療法",
      "presenter": "Joshua Wang",
      "presenter_title": "Founder/ CEO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028pcw926.jpg",
      "category": "Immunotherapy・Gene Therapy"
    },
    {
      "id": 9,
      "name": "Coastar Therapeutics",
      "description": "創新細胞膜包覆大分子藥物技術",
      "presenter": "Chongyang Luo",
      "presenter_title": "COO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028zr44k6.jpg",
      "category": "New Drug Development"
    },
    {
      "id": 10,
      "name": "Myrobalan Therapeutics",
      "description": "促進髓鞘再⽣新型⼝服神經修復藥物",
      "presenter": "Jing Wang",
      "presenter_title": "CEO/ Co-Founder",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/2024102820mamy.jpg",
      "category": "New Drug Development"
    },
    {
      "id": 11,
      "name": "Rapafusyn Pharmaceuticals",
      "description": "非降解分子膠FKBP藥物開發平台",
      "presenter": "Sean Hu",
      "presenter_title": "CEO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028hqd7yv.jpg",
      "category": "New Drug Development"
    },
    {
      "id": 12,
      "name": "Qritive",
      "description": "10倍速AI數位病理診斷",
      "presenter": "Bruno Occhipinti",
      "presenter_title": "CEO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/2024102849bl9m.png",
      "category": "Medical Device・Smart Healthcare"
    },
    {
      "id": 13,
      "name": "HistoSonics",
      "description": "非侵入性聲波技術震碎肝臟腫瘤細胞",
      "presenter": "Josh King",
      "presenter_title": "Vice President",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241105/20241105jwz2nv.webp",
      "category": "Medical Device・Smart Healthcare"
    },
    {
      "id": 14,
      "name": "Niramai",
      "description": "以熱成像AI提高25%乳癌篩檢精準度",
      "presenter": "Vicky Nanda",
      "presenter_title": "COO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241105/202411050pm3e7.jpg",
      "category": "Medical Device・Smart Healthcare"
    },
    {
      "id": 15,
      "name": "PRISM BioLab",
      "description": "以擬肽小分子調控蛋白質交互作用開發新藥",
      "presenter": "Dai Takehara",
      "presenter_title": "President & CEO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241106/20241106hfai10.jpg",
      "category": "New Drug Development"
    },
    {
      "id": 16,
      "name": "SYNCELL",
      "description": "空間蛋白體學必備利器-可抓式顯微系統",
      "presenter": "Jung-Chi Liao",
      "presenter_title": "Founder / CEO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241128/20241128joospa.png",
      "category": "New Drug Development"
    },
    {
      "id": 17,
      "name": "Pharmosa Biopharm",
      "description": "長效緩釋之肺部藥物遞送平台",
      "presenter": "Pei Kan",
      "presenter_title": "Co-Founder / CEO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241128/20241128hh91l3.jpg",
      "category": "New Drug Development"
    },
    {
      "id": 18,
      "name": "Cytonus",
      "description": "以去核幹細胞為載體之精準藥物遞送平台",
      "presenter": "Remo Moomiaie-Qajar",
      "presenter_title": "CEO",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241202/20241202s7kcz8.jpg",
      "category": "New Drug Development"
    }
  ],
  "schedule": [
    {
      "id": 1,
      "day": "December 3",
      "events": [
        {
          "time": "10:00-10:10",
          "title": "Opening Remark",
          "type": "ceremony"
        },
        {
          "time": "10:10-10:50",
          "title": "AI-Driven Innovations and Opportunities in Drug Discovery",
          "type": "keynote",
          "speaker": "Ettikan Karuppiah, Director & Technologist, NVIDIA"
        },
        {
          "time": "10:50-11:30",
          "title": "Advancing Generative AI in Biomedicine: Next Steps and Opportunities",
          "type": "keynote",
          "speaker": "Keren Priyadarshini, Healthcare Lead, Microsoft Asia"
        },
        {
          "time": "11:30-13:00",
          "title": "Lunch Break",
          "type": "break"
        },
        {
          "time": "13:00-14:00",
          "title": "Investing in the Future of Healthcare: Trends and Opportunities in 2025",
          "type": "fireside_chat",
          "moderator": "Charles Lin, Principal, illumina Ventures",
          "panelists": [
            "Robert Mittendorff, General Partner & Head of Healthcare, B Capital",
            "Ian Chiang, Partner, Flare Capital Partners",
            "Nate Chang, Operating Partner, Playground Global",
            "Cheryl Cheng, Founder, Vive Collective"
          ]
        },
        {
          "time": "14:00-14:40",
          "title": "Pitch Session - Regenerative Medicine",
          "type": "pitch_session",
          "presenters": [
            "Tempo Therapeutics｜Westbrook Weaver, Founder & CEO",
            "EyeYon｜Nahum Ferera, Co-Founder & CEO",
            "EpiBone｜Nina Tandon, CEO"
          ]
        },
        {
          "time": "14:40-15:10",
          "title": "Coffee Break",
          "type": "break"
        },
        {
          "time": "15:10-16:00",
          "title": "Pitch Session - Immunotherapy・Gene Therapy",
          "type": "pitch_session",
          "presenters": [
            "ImmuneBridge｜Nina Horowitz, CSO",
            "Cirsium Biosciences｜Jake Connors, Co-Founder & CTO",
            "Rejuvenate Bio｜Daniel Oliver, Co-Founder & CEO",
            "Verlmmune｜Joshua Wang, Founder & CEO"
          ]
        },
        {
          "time": "16:00-16:40",
          "title": "Pitch Session - New Drug Development (I)",
          "type": "pitch_session",
          "presenters": [
            "SYNCELL｜Jung-Chi Liao, Founder & CEO",
            "Pharmosa Biopharm｜Pei Kan, Co-Founder & CEO",
            "Coastar Therapeutics｜Chongyang Luo, COO"
          ]
        },
        {
          "time": "16:40-17:30",
          "title": "Post-Event Networking",
          "type": "networking"
        }
      ]
    }
  ],
  "pastEvents": [
    {
      "id": 1,
      "year": 2024,
      "image": "https://expo.taiwan-healthcare.org/zh/medtex/2024",
      "link": "https://expo.taiwan-healthcare.org/zh/medtex/2024"
    },
    {
      "id": 2,
      "year": 2023,
      "image": "https://expo.taiwan-healthcare.org/zh/news/0s1o793l55fahub5",
      "link": "https://expo.taiwan-healthcare.org/zh/news/0s1o793l55fahub5"
    }
  ],
  "registrationPage": {
    "packages": [
      {
        "id": "conference_only",
        "name": "Startup Forum",
        "price": "$79", 
        "description": [
          "Access to all sessions",
          "Networking opportunities",
          "Lunch included"
        ]
      },
      {
        "id": "conference_and_party",
        "name": "Startup Forum + Networking Party",
        "price": "$199",
        "description": [
          "Access to all sessions",
          "Networking opportunities",
          "Lunch included",
          "Live music",
          "Drinks and snacks",
          "Networking"
        ]
      }
    ],
    "notes": {
      "deadline": "Only a limited number of spots are available. Register early to secure your place.",
      "terms": [
        "Cancellations and refunds are not accepted for this event.",
        "In the event of force majeure (e.g., natural disasters), the organizer reserves the right to postpone or cancel the event.",
        "By registering, you agree to allow the organizer to collect and use your personal information for event-related communication and follow-up notifications."
      ]
    }
  },
  "companyTypes": [
    { "value": "startup", "label": "Startup" },
    { "value": "sme", "label": "Small/Medium Enterprise" },
    { "value": "listed", "label": "Listed Company" },
    { "value": "investor", "label": "Investment Institution / VC" },
    { "value": "academic", "label": "Academic/Research Institution" },
    { "value": "government", "label": "Government / Association" },
    { "value": "other", "label": "Other" }
  ],
  "startup_teams": [
    {
      "id": 1,
      "name": "Tempo Therapeutics",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410285ts46s.jpg",
      "description": "微孔凝膠組織再生全新材料",
      "country": "United States",
      "lead_investors": "Khosla Ventures, MPM Capital",
      "status": "published",
      "created_at": "2023-10-15T08:30:00Z",
      "updated_at": "2024-05-20T14:15:00Z"
    },
    {
      "id": 2,
      "name": "EyeYon",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028xqekka.jpeg",
      "description": "人工眼角膜移植新科技！",
      "country": "Israel",
      "lead_investors": "TriVentures, BRM Group",
      "status": "published",
      "created_at": "2023-11-05T10:45:00Z",
      "updated_at": "2024-06-10T09:20:00Z"
    },
    {
      "id": 3,
      "name": "EpiBone",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028y81103.jpeg",
      "description": "創新脂肪幹細胞製程生成骨移植物",
      "country": "United States",
      "lead_investors": "Pier 70 Ventures, SoftBank Vision Fund",
      "status": "published",
      "created_at": "2023-09-28T15:20:00Z",
      "updated_at": "2024-05-15T11:30:00Z"
    },
    {
      "id": 4,
      "name": "Arbor Biotechnologies",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410280h2pfw.jpg",
      "description": "張鋒團隊！全球最新高效CRISPR平台",
      "country": "United States",
      "lead_investors": "Arch Venture Partners, Forestry LLC",
      "status": "published",
      "created_at": "2023-12-10T09:15:00Z",
      "updated_at": "2024-06-05T16:40:00Z"
    },
    {
      "id": 5,
      "name": "ImmuneBridge",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028r782rx.png",
      "description": "免疫幹細胞擴增技術x精準基因工程",
      "country": "United States",
      "lead_investors": "Versant Ventures, OrbiMed",
      "status": "published",
      "created_at": "2023-10-18T11:30:00Z",
      "updated_at": "2024-05-25T13:45:00Z"
    },
    {
      "id": 6,
      "name": "Cirsium Biosciences",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028e18olj.jpg",
      "description": "獨創植物細胞生產病毒載體技術",
      "country": "Canada",
      "lead_investors": "Amplitude Ventures, Teralys Capital",
      "status": "published",
      "created_at": "2023-11-20T09:25:00Z",
      "updated_at": "2024-06-12T10:35:00Z"
    },
    {
      "id": 7,
      "name": "Rejuvenate Bio",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028n6eq6u.jpg",
      "description": "哈佛團隊研發老化疾病基因療法",
      "country": "United States",
      "lead_investors": "F-Prime Capital, RA Capital Management",
      "status": "published",
      "created_at": "2023-09-05T14:10:00Z",
      "updated_at": "2024-05-28T11:50:00Z"
    },
    {
      "id": 8,
      "name": "Verlmmune",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028pcw926.jpg",
      "description": "抗腫瘤免疫重定向創新療法",
      "country": "United States",
      "lead_investors": "ARCH Venture Partners, Longitude Capital",
      "status": "published",
      "created_at": "2023-12-03T08:45:00Z",
      "updated_at": "2024-06-15T15:20:00Z"
    },
    {
      "id": 9,
      "name": "Coastar Therapeutics",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028zr44k6.jpg",
      "description": "創新細胞膜包覆大分子藥物技術",
      "country": "United States",
      "lead_investors": "Polaris Partners, Google Ventures",
      "status": "published",
      "created_at": "2023-10-25T10:15:00Z",
      "updated_at": "2024-05-30T12:40:00Z"
    },
    {
      "id": 10,
      "name": "Myrobalan Therapeutics",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/2024102820mamy.jpg",
      "description": "促進髓鞘再⽣新型⼝服神經修復藥物",
      "country": "United States",
      "lead_investors": "Atlas Venture, 5AM Ventures",
      "status": "published",
      "created_at": "2023-11-15T13:20:00Z",
      "updated_at": "2024-06-08T09:30:00Z"
    },
    {
      "id": 11,
      "name": "Rapafusyn Pharmaceuticals",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028hqd7yv.jpg",
      "description": "非降解分子膠FKBP藥物開發平台",
      "country": "United States",
      "lead_investors": "Frazier Healthcare Partners, Omega Funds",
      "status": "published",
      "created_at": "2023-09-18T15:40:00Z",
      "updated_at": "2024-05-22T14:25:00Z"
    },
    {
      "id": 12,
      "name": "Qritive",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/2024102849bl9m.png",
      "description": "10倍速AI數位病理診斷",
      "country": "Singapore",
      "lead_investors": "Sequoia India, MassMutual Ventures",
      "status": "published",
      "created_at": "2023-10-10T12:50:00Z",
      "updated_at": "2024-06-02T11:15:00Z"
    },
    {
      "id": 13,
      "name": "HistoSonics",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241105/20241105jwz2nv.webp",
      "description": "非侵入性聲波技術震碎肝臟腫瘤細胞",
      "country": "United States",
      "lead_investors": "Johnson & Johnson Innovation, Venture Investors",
      "status": "published",
      "created_at": "2023-09-12T11:35:00Z",
      "updated_at": "2024-05-18T13:25:00Z"
    },
    {
      "id": 14,
      "name": "Niramai",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241105/202411050pm3e7.jpg",
      "description": "以熱成像AI提高25%乳癌篩檢精準度",
      "country": "India",
      "lead_investors": "Pi Ventures, Axilor Ventures",
      "status": "published",
      "created_at": "2023-11-08T10:20:00Z",
      "updated_at": "2024-06-05T09:55:00Z"
    },
    {
      "id": 15,
      "name": "PRISM BioLab",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241106/20241106hfai10.jpg",
      "description": "以擬肽小分子調控蛋白質交互作用開發新藥",
      "country": "Japan",
      "lead_investors": "Mitsubishi UFJ Capital, UTEC",
      "status": "published",
      "created_at": "2023-10-30T09:40:00Z",
      "updated_at": "2024-05-27T15:10:00Z"
    },
    {
      "id": 16,
      "name": "SYNCELL",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241128/20241128joospa.png",
      "description": "空間蛋白體學必備利器-可抓式顯微系統",
      "country": "Taiwan",
      "lead_investors": "Taiwania Capital, Verge HealthTech Fund",
      "status": "published",
      "created_at": "2023-11-25T14:30:00Z",
      "updated_at": "2024-06-10T10:45:00Z"
    },
    {
      "id": 17,
      "name": "Pharmosa Biopharm",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241128/20241128hh91l3.jpg",
      "description": "長效緩釋之肺部藥物遞送平台",
      "country": "Taiwan",
      "lead_investors": "CDIB Capital, Morningside Ventures",
      "status": "published",
      "created_at": "2023-09-22T13:15:00Z",
      "updated_at": "2024-05-20T10:30:00Z"
    },
    {
      "id": 18,
      "name": "Cytonus",
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241202/20241202s7kcz8.jpg",
      "description": "以去核幹細胞為載體之精準藥物遞送平台",
      "country": "United States",
      "lead_investors": "Alexandria Venture Investments, Illumina Ventures",
      "status": "published",
      "created_at": "2023-10-15T12:05:00Z",
      "updated_at": "2024-06-01T11:20:00Z"
    }
  ],
  "startup_representatives": [
    {
      "id": 1,
      "team_id": 1,
      "name": "Westbrook Weaver",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410285ts46s.jpg",
      "title": "Founder/CEO"
    },
    {
      "id": 2,
      "team_id": 2,
      "name": "Nahum Ferera",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028xqekka.jpeg",
      "title": "CEO/Co-Founder"
    },
    {
      "id": 3,
      "team_id": 3,
      "name": "Nina Tandon",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028y81103.jpeg",
      "title": "CEO"
    },
    {
      "id": 4,
      "team_id": 4,
      "name": "David Cheng",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410280h2pfw.jpg",
      "title": "CTO"
    },
    {
      "id": 5,
      "team_id": 5,
      "name": "Nina Horowitz",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028r782rx.png",
      "title": "CSO"
    },
    {
      "id": 6,
      "team_id": 6,
      "name": "Jake Connors",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028e18olj.jpg",
      "title": "CTO/Co-Founder"
    },
    {
      "id": 7,
      "team_id": 7,
      "name": "Daniel Oliver",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028n6eq6u.jpg",
      "title": "CEO/Co-Founder"
    },
    {
      "id": 8,
      "team_id": 8,
      "name": "Joshua Wang",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028pcw926.jpg",
      "title": "Founder/CEO"
    },
    {
      "id": 9,
      "team_id": 9,
      "name": "Chongyang Luo",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028zr44k6.jpg",
      "title": "COO"
    },
    {
      "id": 10,
      "team_id": 10,
      "name": "Jing Wang",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/2024102820mamy.jpg",
      "title": "CEO/Co-Founder"
    },
    {
      "id": 11,
      "team_id": 11,
      "name": "Sean Hu",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028hqd7yv.jpg",
      "title": "CEO"
    },
    {
      "id": 12,
      "team_id": 12,
      "name": "Bruno Occhipinti",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/2024102849bl9m.png",
      "title": "CEO"
    },
    {
      "id": 13,
      "team_id": 13,
      "name": "Josh King",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241105/20241105jwz2nv.webp",
      "title": "Vice President"
    },
    {
      "id": 14,
      "team_id": 14,
      "name": "Vicky Nanda",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241105/202411050pm3e7.jpg",
      "title": "COO"
    },
    {
      "id": 15,
      "team_id": 15,
      "name": "Dai Takehara",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241106/20241106hfai10.jpg",
      "title": "President & CEO"
    },
    {
      "id": 16,
      "team_id": 16,
      "name": "Jung-Chi Liao",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241128/20241128joospa.png",
      "title": "Founder/CEO"
    },
    {
      "id": 17,
      "team_id": 17,
      "name": "Pei Kan",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241128/20241128hh91l3.jpg",
      "title": "Co-Founder/CEO"
    },
    {
      "id": 18,
      "team_id": 18,
      "name": "Remo Moomiaie-Qajar",
      "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241202/20241202s7kcz8.jpg",
      "title": "CEO"
    }
  ],
  "startup_investments": [
    {
      "id": 1,
      "team_id": 1,
      "year_founded": 2017,
      "total_funding": "$45M",
      "annual_revenue": "$5M",
      "is_pre_revenue": false,
      "funding_round": "Series B",
      "amount_raised": "$30M",
      "valuation": "$120M",
      "on_market": "Private"
    },
    {
      "id": 2,
      "team_id": 2,
      "year_founded": 2015,
      "total_funding": "$36M",
      "annual_revenue": "$2.5M",
      "is_pre_revenue": false,
      "funding_round": "Series B",
      "amount_raised": "$20M",
      "valuation": "$90M",
      "on_market": "Private"
    },
    {
      "id": 3,
      "team_id": 3,
      "year_founded": 2012,
      "total_funding": "$56M",
      "annual_revenue": "$8M",
      "is_pre_revenue": false,
      "funding_round": "Series C",
      "amount_raised": "$35M",
      "valuation": "$180M",
      "on_market": "Private"
    },
    {
      "id": 4,
      "team_id": 4,
      "year_founded": 2018,
      "total_funding": "$125M",
      "annual_revenue": "$0",
      "is_pre_revenue": true,
      "funding_round": "Series B",
      "amount_raised": "$75M",
      "valuation": "$300M",
      "on_market": "Private"
    },
    {
      "id": 5,
      "team_id": 5,
      "year_founded": 2016,
      "total_funding": "$78M",
      "annual_revenue": "$0",
      "is_pre_revenue": true,
      "funding_round": "Series B",
      "amount_raised": "$45M",
      "valuation": "$220M",
      "on_market": "Private"
    },
    {
      "id": 6,
      "team_id": 6,
      "year_founded": 2019,
      "total_funding": "$32M",
      "annual_revenue": "$1.2M",
      "is_pre_revenue": false,
      "funding_round": "Series A",
      "amount_raised": "$20M",
      "valuation": "$95M",
      "on_market": "Private"
    },
    {
      "id": 7,
      "team_id": 7,
      "year_founded": 2018,
      "total_funding": "$58M",
      "annual_revenue": "$0",
      "is_pre_revenue": true,
      "funding_round": "Series B",
      "amount_raised": "$35M",
      "valuation": "$180M",
      "on_market": "Private"
    },
    {
      "id": 8,
      "team_id": 8,
      "year_founded": 2020,
      "total_funding": "$42M",
      "annual_revenue": "$0",
      "is_pre_revenue": true,
      "funding_round": "Series A",
      "amount_raised": "$30M",
      "valuation": "$150M",
      "on_market": "Private"
    },
    {
      "id": 9,
      "team_id": 9,
      "year_founded": 2017,
      "total_funding": "$47M",
      "annual_revenue": "$3.5M",
      "is_pre_revenue": false,
      "funding_round": "Series B",
      "amount_raised": "$30M",
      "valuation": "$130M",
      "on_market": "Private"
    },
    {
      "id": 10,
      "team_id": 10,
      "year_founded": 2018,
      "total_funding": "$39M",
      "annual_revenue": "$0",
      "is_pre_revenue": true,
      "funding_round": "Series A",
      "amount_raised": "$25M",
      "valuation": "$105M",
      "on_market": "Private"
    },
    {
      "id": 11,
      "team_id": 11,
      "year_founded": 2019,
      "total_funding": "$85M",
      "annual_revenue": "$0",
      "is_pre_revenue": true,
      "funding_round": "Series B",
      "amount_raised": "$60M",
      "valuation": "$240M",
      "on_market": "Private"
    },
    {
      "id": 12,
      "team_id": 12,
      "year_founded": 2017,
      "total_funding": "$28M",
      "annual_revenue": "$4.2M",
      "is_pre_revenue": false,
      "funding_round": "Series B",
      "amount_raised": "$18M",
      "valuation": "$85M",
      "on_market": "Private"
    },
    {
      "id": 13,
      "team_id": 13,
      "year_founded": 2015,
      "total_funding": "$130M",
      "annual_revenue": "$8.5M",
      "is_pre_revenue": false,
      "funding_round": "Series D",
      "amount_raised": "$65M",
      "valuation": "$350M",
      "on_market": "Private"
    },
    {
      "id": 14,
      "team_id": 14,
      "year_founded": 2016,
      "total_funding": "$22M",
      "annual_revenue": "$3.8M",
      "is_pre_revenue": false,
      "funding_round": "Series B",
      "amount_raised": "$15M",
      "valuation": "$75M",
      "on_market": "Private"
    },
    {
      "id": 15,
      "team_id": 15,
      "year_founded": 2013,
      "total_funding": "$65M",
      "annual_revenue": "$5.2M",
      "is_pre_revenue": false,
      "funding_round": "Series C",
      "amount_raised": "$40M",
      "valuation": "$200M",
      "on_market": "Private"
    },
    {
      "id": 16,
      "team_id": 16,
      "year_founded": 2020,
      "total_funding": "$32M",
      "annual_revenue": "$1.8M",
      "is_pre_revenue": false,
      "funding_round": "Series A",
      "amount_raised": "$20M",
      "valuation": "$100M",
      "on_market": "Private"
    },
    {
      "id": 17,
      "team_id": 17,
      "year_founded": 2015,
      "total_funding": "$45M",
      "annual_revenue": "$6.5M",
      "is_pre_revenue": false,
      "funding_round": "Series B",
      "amount_raised": "$28M",
      "valuation": "$120M",
      "on_market": "Private"
    },
    {
      "id": 18,
      "team_id": 18,
      "year_founded": 2017,
      "total_funding": "$70M",
      "annual_revenue": "$0",
      "is_pre_revenue": true,
      "funding_round": "Series B",
      "amount_raised": "$45M",
      "valuation": "$190M",
      "on_market": "Private"
    }
  ],
  "startup_details": [
    {
      "id": 1,
      "team_id": 1,
      "investment_highlights": "市場規模估達100億美元，獨家專利技術能夠顯著加速組織再生過程",
      "core_technology": "微孔凝膠技術平台能夠模擬細胞外基質結構，優化細胞生長環境",
      "target_market": "外科手術修復市場，特別是骨科與傷口癒合",
      "milestones": "預計2025年開始FDA臨床II期試驗，2026年進入歐洲市場"
    },
    {
      "id": 2,
      "team_id": 2,
      "investment_highlights": "全球約有5000萬角膜疾病患者，本產品可大幅降低眼角膜移植困難度",
      "core_technology": "合成角膜材料能夠與人體組織良好結合，降低排斥反應",
      "target_market": "眼科手術市場，特別是角膜移植領域",
      "milestones": "已通過歐盟CE認證，正在進行美國FDA審批過程"
    },
    {
      "id": 3,
      "team_id": 3,
      "investment_highlights": "骨移植市場每年成長10%以上，技術能夠避免傳統骨移植併發症",
      "core_technology": "使用病患自體脂肪幹細胞培養客製化骨骼組織，完全避免排斥問題",
      "target_market": "骨科手術市場，特別是顱顏骨缺損修復領域",
      "milestones": "已完成FDA I/II期臨床試驗，預計2025年上市"
    },
    {
      "id": 4,
      "team_id": 4,
      "investment_highlights": "基因編輯市場規模超過100億美元，技術比現有CRISPR系統精準度高50%",
      "core_technology": "AI驅動的CRISPR工具發現平台，能夠識別並優化全新的基因編輯酶",
      "target_market": "基因治療、生物技術研發工具市場",
      "milestones": "已與三家全球前20大製藥公司簽訂合作研發協議"
    },
    {
      "id": 5,
      "team_id": 5,
      "investment_highlights": "免疫療法市場年成長30%，技術可大幅提高細胞治療產率",
      "core_technology": "獨特的幹細胞增殖及基因工程雙平台技術，提高免疫細胞功能與存活率",
      "target_market": "腫瘤學與自體免疫疾病治療市場",
      "milestones": "已完成臨床前研究，計劃2025年開始I期臨床試驗"
    },
    {
      "id": 6,
      "team_id": 6,
      "investment_highlights": "病毒載體生產成本可降低75%，大幅提高基因療法可及性",
      "core_technology": "植物細胞製程平台，可高效率生產AAV及慢病毒載體，無動物源性成分污染風險",
      "target_market": "基因療法、疫苗生產市場",
      "milestones": "完成GMP生產線建置，已與兩家基因治療公司簽訂供應合約"
    },
    {
      "id": 7,
      "team_id": 7,
      "investment_highlights": "老化相關疾病市場超過3000億美元，技術可同時治療多種老化疾病",
      "core_technology": "使用AAV載體遞送組合基因，調控關鍵老化信號通路，延緩或逆轉組織老化",
      "target_market": "老化相關疾病、寵物醫療市場",
      "milestones": "寵物療法已通過FDA批准，人類臨床I期試驗預計2025年開始"
    },
    {
      "id": 8,
      "team_id": 8,
      "investment_highlights": "相比現有免疫檢查點抑制劑，反應率提高40%，適用腫瘤類型更廣",
      "core_technology": "專利免疫重定向抗體技術，能同時鎖定腫瘤細胞與活化T細胞，增強免疫應答",
      "target_market": "實體腫瘤與血液惡性腫瘤治療市場",
      "milestones": "臨床前研究顯示優於同類產品，預計2025年第一季進入I期臨床"
    },
    {
      "id": 9,
      "team_id": 9,
      "investment_highlights": "創新技術能將大分子藥物口服生物利用度提高10倍以上",
      "core_technology": "專利細胞膜包覆技術，保護藥物分子在胃腸道環境中穩定性並促進吸收",
      "target_market": "大分子藥物制劑市場，糖尿病、自體免疫疾病治療",
      "milestones": "已完成I期臨床試驗，證實技術安全性與初步有效性"
    },
    {
      "id": 10,
      "team_id": 10,
      "investment_highlights": "全球多發性硬化症市場規模超過250億美元，現有治療無法修復髓鞘",
      "core_technology": "小分子藥物能激活少突膠質細胞分化，促進受損神經元髓鞘再生",
      "target_market": "多發性硬化症、周圍神經病變及其他神經退行性疾病",
      "milestones": "臨床I期試驗結果顯示安全性良好，已開始IIa期概念驗證研究"
    },
    {
      "id": 11,
      "team_id": 11,
      "investment_highlights": "分子膠技術為RNA藥物和蛋白質降解劑開創全新治療路徑",
      "core_technology": "創新分子膠平台能特異性結合FKBP蛋白，調控標靶蛋白功能而非降解",
      "target_market": "腫瘤學、免疫學及神經科學藥物市場",
      "milestones": "首個候選藥物已進入GLP毒理研究階段，預計2025年申請臨床試驗"
    },
    {
      "id": 12,
      "team_id": 12,
      "investment_highlights": "病理診斷市場規模超過400億美元，AI能減少70%診斷時間",
      "core_technology": "深度學習病理影像分析平台，可自動檢測與分類多種癌症類型",
      "target_market": "病理診斷、精準醫療、癌症早期篩檢市場",
      "milestones": "已獲得FDA與CE認證，在亞洲10多家醫院部署系統"
    },
    {
      "id": 13,
      "team_id": 13,
      "investment_highlights": "肝腫瘤手術市場每年超過50億美元，技術可完全避免侵入性手術風險",
      "core_technology": "組織聲波解離技術(Histotripsy)通過聚焦超聲波精確破壞目標組織",
      "target_market": "肝腫瘤、腎臟腫瘤及其他實體腫瘤治療市場",
      "milestones": "已獲FDA突破性醫療器械認證，臨床試驗顯示95%治療效果"
    },
    {
      "id": 14,
      "team_id": 14,
      "investment_highlights": "乳癌篩檢市場超過50億美元，技術可增加25%早期檢出率",
      "core_technology": "結合紅外熱成像與AI演算法，無輻射、無接觸檢測乳房異常",
      "target_market": "乳癌篩檢、女性健康市場，特別是開發中國家",
      "milestones": "已在印度和東南亞篩檢超過5萬名女性，獲得多國監管認證"
    },
    {
      "id": 15,
      "team_id": 15,
      "investment_highlights": "蛋白質-蛋白質相互作用藥物市場快速增長，年增速超過15%",
      "core_technology": "專利擬肽化合物庫與AI篩選平台，能靶向傳統「難成藥」蛋白質相互作用",
      "target_market": "腫瘤學、炎症性疾病及纖維化疾病治療市場",
      "milestones": "首個臨床階段藥物已完成II期試驗，另有3個候選藥物處於臨床前研究階段"
    },
    {
      "id": 16,
      "team_id": 16,
      "investment_highlights": "空間生物學市場每年成長40%，技術可提高單細胞蛋白分析準確度100倍",
      "core_technology": "光氣動力學微操作系統，可抓取單個細胞進行超高分辨率蛋白體分析",
      "target_market": "藥物開發、診斷與基礎研究市場",
      "milestones": "已與5家大型製藥公司建立合作關係，首款商業產品已上市"
    },
    {
      "id": 17,
      "team_id": 17,
      "investment_highlights": "肺部給藥系統市場規模超過450億美元，技術可延長藥效達10倍",
      "core_technology": "專利緩釋微粒技術與特殊吸入器設計，提高藥物在肺部滯留時間與均勻分佈",
      "target_market": "哮喘、COPD及囊腫性纖維化藥物市場",
      "milestones": "首款產品在台灣和東南亞獲批上市，美國FDA審核進行中"
    },
    {
      "id": 18,
      "team_id": 18,
      "investment_highlights": "精準藥物遞送市場規模超過650億美元，技術可降低90%全身副作用",
      "core_technology": "以去細胞核的幹細胞外泌體為載體，能特異性靶向腫瘤與發炎組織",
      "target_market": "腫瘤學、自體免疫及神經退行性疾病治療市場",
      "milestones": "完成大型動物安全性研究，計劃2025年初申請首個IND"
    }
  ],
  "startup_products": [
    {
      "id": 1,
      "team_id": 1,
      "name": "TempoPatch",
      "category": "device",
      "stage": "臨床前研究完成，準備進入人體試驗",
      "certificate_country": "美國"
    },
    {
      "id": 2,
      "team_id": 1,
      "name": "TempoMatrix",
      "category": "device",
      "stage": "動物試驗階段",
      "certificate_country": "美國"
    },
    {
      "id": 3,
      "team_id": 2,
      "name": "EndoArt",
      "category": "device",
      "stage": "已通過CE認證，進入歐洲市場",
      "certificate_country": "歐盟"
    },
    {
      "id": 4,
      "team_id": 3,
      "name": "EB-1 Bone Graft",
      "category": "device",
      "stage": "臨床二期試驗",
      "certificate_country": "美國"
    },
    {
      "id": 5,
      "team_id": 4,
      "name": "CRISPR Type V Platform",
      "category": "service",
      "stage": "研發階段，已開放給合作夥伴使用",
      "certificate_country": "N/A"
    },
    {
      "id": 6,
      "team_id": 4,
      "name": "Gene-Edit Pro Kit",
      "category": "device",
      "stage": "已商業化，供研究使用",
      "certificate_country": "美國"
    },
    {
      "id": 7,
      "team_id": 5,
      "name": "ImmuneBoost Platform",
      "category": "service",
      "stage": "研發階段，與製藥合作夥伴使用中",
      "certificate_country": "N/A"
    },
    {
      "id": 8,
      "team_id": 5,
      "name": "IB-201",
      "category": "drug",
      "stage": "IND申請準備中",
      "certificate_country": "美國"
    },
    {
      "id": 9,
      "team_id": 6,
      "name": "PlantVector Platform",
      "category": "service",
      "stage": "已商業化，提供AAV生產服務",
      "certificate_country": "加拿大"
    },
    {
      "id": 10,
      "team_id": 6,
      "name": "PlantAAV Kit",
      "category": "device",
      "stage": "市場銷售中，研究用途",
      "certificate_country": "加拿大、美國"
    },
    {
      "id": 11,
      "team_id": 7,
      "name": "RJV-101",
      "category": "drug",
      "stage": "臨床前研究完成",
      "certificate_country": "美國"
    },
    {
      "id": 12,
      "team_id": 7,
      "name": "PetRejuv",
      "category": "drug",
      "stage": "已獲FDA動物用藭批准",
      "certificate_country": "美國"
    },
    {
      "id": 13,
      "team_id": 8,
      "name": "VIM-201",
      "category": "drug",
      "stage": "IND申請準備中",
      "certificate_country": "美國"
    },
    {
      "id": 14,
      "team_id": 8,
      "name": "VIM-301",
      "category": "drug",
      "stage": "臨床前研究階段",
      "certificate_country": "美國"
    },
    {
      "id": 15,
      "team_id": 9,
      "name": "CoastShield",
      "category": "drug",
      "stage": "臨床I期完成",
      "certificate_country": "美國"
    },
    {
      "id": 16,
      "team_id": 9,
      "name": "CoastCap Platform",
      "category": "service",
      "stage": "已與合作夥伴共同開發中",
      "certificate_country": "N/A"
    },
    {
      "id": 17,
      "team_id": 10,
      "name": "MyroRestore",
      "category": "drug",
      "stage": "臨床IIa期進行中",
      "certificate_country": "美國"
    },
    {
      "id": 18,
      "team_id": 10,
      "name": "MyroNeuro",
      "category": "drug",
      "stage": "臨床前研究階段",
      "certificate_country": "美國"
    },
    {
      "id": 19,
      "team_id": 11,
      "name": "RapaLink-1",
      "category": "drug",
      "stage": "GLP毒理研究階段",
      "certificate_country": "美國"
    },
    {
      "id": 20,
      "team_id": 11,
      "name": "MolGlue Platform",
      "category": "service",
      "stage": "與製藥公司合作開發中",
      "certificate_country": "N/A"
    },
    {
      "id": 21,
      "team_id": 12,
      "name": "QritiveDx",
      "category": "software",
      "stage": "已獲FDA與CE認證",
      "certificate_country": "美國、歐盟"
    },
    {
      "id": 22,
      "team_id": 12,
      "name": "QritiveResearch",
      "category": "software",
      "stage": "商業銷售中",
      "certificate_country": "全球"
    },
    {
      "id": 23,
      "team_id": 13,
      "name": "Edison Platform",
      "category": "device",
      "stage": "臨床試驗階段",
      "certificate_country": "美國"
    },
    {
      "id": 24,
      "team_id": 13,
      "name": "SonoGuide",
      "category": "software",
      "stage": "配合Edison使用中",
      "certificate_country": "美國"
    },
    {
      "id": 25,
      "team_id": 14,
      "name": "Thermalytix",
      "category": "device",
      "stage": "已獲多國監管認證",
      "certificate_country": "印度、新加坡、馬來西亞"
    },
    {
      "id": 26,
      "team_id": 14,
      "name": "SMILE-100",
      "category": "software",
      "stage": "已商業化",
      "certificate_country": "全球"
    },
    {
      "id": 27,
      "team_id": 15,
      "name": "PepMimetic-1",
      "category": "drug",
      "stage": "臨床II期完成",
      "certificate_country": "日本、美國"
    },
    {
      "id": 28,
      "team_id": 15,
      "name": "PeptideMimetic Library",
      "category": "service",
      "stage": "授權給合作夥伴使用中",
      "certificate_country": "全球"
    },
    {
      "id": 29,
      "team_id": 16,
      "name": "GrabCell System",
      "category": "device",
      "stage": "商業銷售中",
      "certificate_country": "台灣、美國"
    },
    {
      "id": 30,
      "team_id": 16,
      "name": "SpatialProteome Software",
      "category": "software",
      "stage": "商業銷售中",
      "certificate_country": "全球"
    },
    {
      "id": 31,
      "team_id": 17,
      "name": "PulmoHaler",
      "category": "device",
      "stage": "市場銷售中",
      "certificate_country": "台灣、馬來西亞、泰國"
    },
    {
      "id": 32,
      "team_id": 17,
      "name": "LungShield",
      "category": "drug",
      "stage": "FDA審核中",
      "certificate_country": "台灣"
    },
    {
      "id": 33,
      "team_id": 18,
      "name": "CellCap Platform",
      "category": "service",
      "stage": "研發階段",
      "certificate_country": "N/A"
    },
    {
      "id": 34,
      "team_id": 18,
      "name": "CytoDeliver-1",
      "category": "drug",
      "stage": "大型動物研究完成",
      "certificate_country": "美國"
    }
  ]
}
